EN
HI
Summary
As of 1 Sep, 2026, Beta Drugs stock price is ₹2206.8. During the trading session, the stock has moved between an intraday low of ₹2180.00 and an intraday high of ₹2277.00. Over the last 52 weeks, Beta Drugs has traded between ₹990.10 and ₹2807.90.
The stock has recorded a trading volume of 12,964 shares, with a market capitalization of ₹11085872. Its Average Traded Price (ATP) is ₹2211.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2206.80.
Beta Drugs has an upper circuit limit of ₹2711.80 and a lower circuit limit of ₹1808.00. The total value traded stands at ₹2.87 CR, and the delivery percentage for the day is 49.99%.
The stock is currently traded with a market lot size of 1. Beta Drugs also offers a dividend yield of 0%.
Beta Drugs share price chart
Beta Drugs Share Key Metrics
Volume
12964.00
Market Cap
2446.43 CR
LTQ@LTP
1@2206.80
ATP
2211.24
Var Margin
100 %
Circuit Range
1808-2711.8
Delivery %
49.99 %
Value
2.87 CR
ASM/GSM
No
Market Lot
1
Beta Drugs Fundamentals
P/E Ratio
60.59
P/B Ratio
9.58
Div. Yield
0
Sector P/E
41.23
Sector P/B
3.52
Sec. Div. Yield
0.51
Beta Drugs Resistance and Support
Pivot 2261.57
Resistance
First Resistance
2370.14
Second Resistance
2480.37
Third Resistance
2588.94
Support
First Support
2151.34
Second Support
2042.77
Third Support
1932.54
Beta Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 01 2026 | 2277 | 2206.8 | -2.35% | 2277 | 2180 |
| Mon Aug 31 2026 | 2190 | 2259.89 | 2.68% | 2371.8 | 2153 |
| Fri Aug 28 2026 | 2194.19 | 2201 | 0.31% | 2253 | 2166.19 |
Beta Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-20 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2026-01-09 | Others |
Beta Drugs Management
| Name | Position |
|---|---|
| Rahul Batra | Chairman & Managing Director |
| Varun Batra | Joint Managing Director |
Beta Drugs Similar Stocks
Ind-Swift Laboratories Ltd.
368.15
3.28 (0.90%)
Solara Active Pharma Sciences Ltd.
643.45
10.80 (1.71%)
Dishman Carbogen Amcis Ltd.
181.83
3.49 (1.96%)
Hikal Ltd.
198.54
-2.87 (1.42%)
Dr Agarwals Eye Hospital Ltd.
5309.50
43.50 (0.83%)
Fredun Pharmaceuticals Ltd.
1497.80
50.90 (3.52%)
Panacea Biotec Ltd.
390.90
3.80 (0.98%)
Sai Parenteral's Ltd.
518.75
-1.45 (0.28%)
Indoco Remedies Ltd.
243.84
0.50 (0.21%)
Beta Drugs FAQs
The Buying Price of Beta Drugs share is 2206.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beta Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beta Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beta Drugs shares is 60.59. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beta Drugs shares is 9.58. Useful to assess the stock's value relative to its book value.
To assess Beta Drugs’s valuation compare Sector P/E, P/B which are 41.23 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beta Drugs is 2446.43 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beta Drugs share price is 2807.90 & 990.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beta Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
